QT
NWBO

Quantbot Technologies’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Quantbot Technologies’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,488
Closed -$21K – 1642
2015
Q3 		$21K Buy
3,488
+2,688
+336% +$25.1K ﹤0.01% 1022
2015
Q2 		$7K Buy
+800
New +$7.01K ﹤0.01% 1015
2014
Q3 		– Sell
-11,900
Closed -$79K – 1657
2014
Q2 		$79K Buy
+11,900
New +$75.7K 0.01% 815

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quantbot Technologies's NWBO Position: Q4 2015 in Review

Quantbot Technologies sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2015, closing a stake of 3,488 shares — an estimated $21K sold.

Quantbot Technologies first reported a position in NWBO in Q2 2014 and held it in 3 quarters. The position peaked at $79K in Q2 2014. 80 funds tracked by Wall St. Rank hold NWBO as of Q4 2015.

  • Quantbot Technologies reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2015 after selling out during the quarter.
  • Quantbot Technologies sold 3,488 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2015, an estimated $21K.
  • Quantbot Technologies first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2014 and held it in 3 quarters.
  • Quantbot Technologies's Northwest Biotherapeutics, Inc. Common stock position peaked at $79K in Q2 2014.
  • 80 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2015.

Based on Quantbot Technologies's 13F filing for Q4 2015, filed 22 Jan 2016.